01
- Entity Type
- Diseases
- Relation Groups
- 4
- Relation Preview
- 32
Basic Information
Grouped by core information, identifiers, and descriptions.
Current candidates are inferred from disease-target-ingredient-herb paths and do not represent a formal recommendation ranking.
Core Information
- Disease Name
- Lipodystrophy
- Standard Disease Name
- lipodystrophy
- MeSH Tree
- No data
- ICD-10
- E88.1
Identifiers
- DO ID
- No data
- MeSH ID
- D008060
- OMIM ID
- MTHU037286
- UMLS ID
- C0023787
- HPO ID
- No data
Description and Extensions
- Description
- NCI2016_02D:A congenital or acquired disorder characterized by abnormal loss or redistribution of the adipose tissue in the body.|MSH2017_2016_08_12:A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.|HPO2016_07_04:Degenerative changes of the fat tissue. [HPO:curators]|CSP2006:collection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat; includes total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy.
Related
Related Entities
Direct relations and traceable candidates grouped by relation type.
Candidate Ingredients
target disease -> ingredient target8 Ingredients
02
(−)-Alloaromadendrene
No data
03
()-2-Carene
No data
04
()-Aromadendrene
No data
05
06
()-Beta-Pinene
No data
07
()-Cuparene
No data
08
()-Ledene
No data